Hitomi Tani

  • Citations Per Year
Learn More
To evaluate the usefulness of magnetic resonance imaging (MRI) for detection and quantification of myocardial damage related to clinical phases and cardiac function during eosinophilic myocarditis. Four eosinophilic myocarditis patients received seven MRI studies. The left ventricular myocardium was divided into 48 layers, and we quantified the extent of(More)
To evaluate the capability of MRI to differentiate cardiac amyloidosis (CA), end-stage hypertrophic cardiomyopathy (HCM), and hypertensive heart disease (HHD), which are important etiologies of left ventricular hypertrophy (LVH) and heart failure. We enrolled 26 patients presenting with both LVH and heart failure: six with CA, nine with end-stage HCM, and(More)
A study was conducted to evaluate the sensitivity of computer-aided detection (CAD) with full-field digital mammography in detection of breast cancer, based on mammographic appearance and histopathology. Retrospectively, CAD sensitivity was assessed in total group of 152 cases for subgroups based on breast density, mammographic presentation, lesion size,(More)
BACKGROUND AND PURPOSE The aim of this study was to compare the accumulation of 4-borono-2-(18)F-fluoro-phenylalanine ((18)F-BPA) with that of (18)F-fluorodeoxyglucose ((18)F-FDG) in head and neck cancers, and to assess the usefulness of (18)F-FDG PET for screening candidates for boron neutron capture therapy (BNCT). MATERIAL AND METHODS Twenty patients(More)
Obscure gastrointestinal bleeding is often a diagnostic challenge for the primary care physician, but with improvements in diagnostic testing the cause of such blood loss is determined in most patients. However, in approximately 5% of the cases, the source of bleeding is not identifiable. One common etiology in patients younger than 40 years of age is(More)
BACKGROUND The purpose of this study was to determine whether brain metastases from HER2-positive breast cancer could be detected noninvasively using positron emission tomography (PET) with (64)Cu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-trastuzumab. METHODS PET was performed on five patients with brain metastases from HER2-positive(More)